Mechanistically, the oncogenic action of DSCAM-AS1 was demonstrated to interact with nuclear ribonucleoprotein hnRNPL in breast cancer cells, which has been found to facilitate progression of breast cancer and induce resistance to tamoxifen [14]. Here, HNRNPL is linked to breast cancer.